Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced that on February 6, 2026, the Compensation Committee of Recursion's Board of ...
Abstract: An efficient recursive aggregated centered transition matrix (T-matrix) algorithm (RACTMA) to analyze electromagnetic scattering from many randomly distributed obstacles is derived. The ...
Abstract: Building collapses, irrespective of structure type or location, result in global tragedies. Rapid rescue efforts are essential, especially within the critical three-day window for trapped ...
The spotlight is now firmly on clinical validation for Exscientia following its merger with Recursion Pharmaceuticals. The company’s core artificial intelligenc ...